Gene Therapy Market Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 200+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo!...
Taysha Gene Therapies, Inc. (TSHA)
Company Research
Source: Yahoo! Finance
Current strategies involve modified viral vectors for gene delivery, with applications in chronic diseases like SMA, retinal, and metabolic conditions. Partnerships and advancements are driving innovative treatments. Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering. This "Gene Therapy - Competitive landscape, 2026," report provides comprehensive insights about 180+ companies and 200+ drugs in Gene Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Report Highlights In July 2024, Miltenyi Biotec, announced the signing of a Letter of Intent with the Translational Health Science and Technology Institute (THSTI). With this partnership, both organizations aim to address the growing need for innovative treatments in the fight again
Show less
Read more
Impact Snapshot
Event Time:
TSHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSHA alerts
High impacting Taysha Gene Therapies, Inc. news events
Weekly update
A roundup of the hottest topics
TSHA
News
- Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.MarketBeat
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]Yahoo! Finance
- Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]Yahoo! Finance
- Taysha Gene Therapies Inc. (TSHA): A Promising Biotech on Rett Syndrome Drug Prospects [Yahoo! Finance]Yahoo! Finance
TSHA
Earnings
- 11/4/25 - In-Line
TSHA
Sec Filings
- 2/27/26 - Form 144
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- TSHA's page on the SEC website